Skip to content

XH-1 Neuromuscular Stimulator

by California Medical Research Institute

510(k) K950550

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK950550 Date4 Dec 1996ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
IPF
Device Class
Class II
Regulation
21 CFR Part 890.5850
Advisory Committee
Physical Medicine
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The XH-1 Neuromuscular Stimulator is a powered device classified as a neuromuscular electrical stimulator (Nomenclature: IPF). It delivers controlled electrical impulses to stimulate muscle contraction and relaxation, aiding in the management of muscle spasms and improving neuromuscular function.

This device operates using two AA batteries (3 volts) and delivers a fixed-frequency biphasic waveform at 0.9 Hz via electrodes applied to the skin with a water-moistened paper towel. Supplied as a reusable device, it requires no sterilisation and is intended for use in clinical settings such as physical therapy or rehabilitation. Authorised under FDA 510(k) clearance (K950550), it adheres to traditional review standards for physical medicine applications.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of muscle conditions is the XH-1 Neuromuscular Stimulator designed to help manage, and how does it work?

    The XH-1 is designed to manage muscle spasms and improve neuromuscular function by delivering controlled electrical impulses to stimulate muscle contraction and relaxation. It uses a fixed-frequency biphasic waveform at 0.9 Hz, applied via electrodes placed on the skin with a water-moistened paper towel. This approach is commonly used in physical therapy or rehabilitation settings to encourage muscle activity and reduce spasticity.

  • How is the XH-1 Neuromuscular Stimulator powered, and how long can it be used continuously before needing replacement?

    The XH-1 operates using two AA batteries (3 volts) and does not specify a runtime duration in the provided data. Since it is a reusable device, users would need to monitor battery life and replace them as needed to maintain continuous operation. The exact runtime would depend on battery capacity and usage frequency.

  • Is the XH-1 Neuromuscular Stimulator intended for single-use or reusable applications, and what maintenance is required?

    The XH-1 is explicitly described as a reusable device and does not require sterilization. Maintenance primarily involves replacing the AA batteries when depleted and ensuring the electrodes and application materials (like water-moistened paper towels) are clean and functional for each use.

  • What are the key specifications of the XH-1’s electrical output, and how is it applied to the patient?

    The device delivers a fixed-frequency biphasic waveform at 0.9 Hz through electrodes applied to the skin. The electrodes are used with a water-moistened paper towel to facilitate conductivity. The waveform and frequency are designed to stimulate muscle contraction and relaxation, aiding in neuromuscular function without requiring invasive procedures.

  • How was the XH-1 Neuromuscular Stimulator reviewed and approved by the FDA, and what does that mean for clinical use?

    The XH-1 was cleared via an FDA 510(k) submission (K950550) under the Traditional Review pathway, determined to be Substantially Equivalent (SESE) to a legally marketed predicate device. This clearance falls under the Physical Medicine advisory committee category (product code IPF), meaning it was evaluated for safety and effectiveness in applications like muscle stimulation for rehabilitation or spasm management in clinical settings.